SLC1A2 and schizophrenia: Postmortem studies have identified abnormalities in astrocytic glutamate transporters in individuals with schizophrenia, such as reduced expression of the major glial glutamate transporter, EAAT2 (GLT-1), in specific regions, including the parahippocampal cortex.